Sorafenib Stada 400 mg filmom obložene tablete
| Name | Sorafenib Stada 400 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-429355680 |
| Active Substance | sorafenibtosilat |
| Composition | jedna filmom obložena tableta sadrži 400 mg sorafeniba (u obliku tosilata). |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | STADA Arzneimittel AG, Bad Vilbel, Njemačka Remedica Ltd., Limassol, Cipar PharOS MT Ltd, Birzebbugia, Malta Laboratori Fundacio Dau, Barcelona, Španjolska |
| Marketing Authorisation Holder | Stada d.o.o., Hercegovačka 14, Zagreb, Hrvatska |
| Marketing Authorisation Date | 10.06.2021 |
| MA Period of Validity | 10.06.2026 |
| Classification Number | UP/I-530-09/20-01/84 |
| Registration Number | 381-12-01/154-21-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01XE05 |
| Marketing status | Temporarily unavailable |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
